Primary ovarian insufficiency and fertility preservation: review article

2018

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.5114/jogi.2018.81046
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Introduction: Female fertility and the ovarian reserve decrease with age.Material and methods: Review of literature about the primary ovarian insufficiency (POI) and methods of fertility preservation to define women at risk of POI and their fertility saving options.Results: Women with a family history of POI, fragile X syndrome primary ovarian insufficiency mutation (FXPOI), autoimmune thyroiditis, Addison's disease, exposure to toxins and viral infection are at high risk of POI.In-vitro-fertilization success improved after introduction of oocyte (or embryo) vitrification.Transplantation of the cryo-preserved ovarian tissue could be a fertility preservation option.Transplantation of the cryo-preserved ovarian tissue is an outpatient procedure, which restores hormonal function and fertility.After ovarian tissue transplantation women can conceive normally without medical assistance.Conclusions: The use of donor oocytes is the only treatment for women at risk of POI.The in-vitro-fertilization outcome improved after introduction of oocyte (or embryo) vitrification.Transplantation of the cryo-preserved ovarian tissue is an outpatient procedure, which restores hormonal function and fertility.